<DOC>
	<DOCNO>NCT01943045</DOCNO>
	<brief_summary>The purpose study determine safety , tolerability , activity NGM282 patient Type 2 Diabetes .</brief_summary>
	<brief_title>Phase 2 Study NGM282 Patients With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<criteria>Males female , 18 70 year age , inclusive BMI range 2440 kg/m2 , inclusive No active coronary artery disease Resting heart rate range 40100 bpm Diagnosis Type 1 diabetes History significant hypersensitivity , intolerance , allergy drug compound , food , substance</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>